TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA
Clinical trial NCT01732367 · COMPLETED
Trial details
- NCT number
- NCT01732367
- Sponsor
- Keimyung University Dongsan Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2016-03-01
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.